ERYTHEMA DYSCHROMICUM PERSTANS

Clinical trials for ERYTHEMA DYSCHROMICUM PERSTANS explained in plain language.

Never miss a new study

Get alerted when new ERYTHEMA DYSCHROMICUM PERSTANS trials appear

Sign up with your email to follow new studies for ERYTHEMA DYSCHROMICUM PERSTANS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Common bleeding drug tested for stubborn skin stains

Disease control Recruiting now

This study is testing whether a medication called tranexamic acid can reduce skin discoloration caused by two conditions: lichen planus pigmentosus and erythema dyschromicum perstans. There are currently no consistently effective treatments for these skin conditions. Researchers …

Matched conditions: ERYTHEMA DYSCHROMICUM PERSTANS

Phase: PHASE2 • Sponsor: Henry Ford Health System • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

ERYTHEMA DYSCHROMICUM PERSTANS

Get alerted when new ERYTHEMA DYSCHROMICUM PERSTANS trials appear

Common bleeding drug tested for stubborn skin stains